GEM05 for Patients With Multiple Myeloma More Than 65 Years Old
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The primary objective is to analyze and compare the efficacy, the response rate, the CR and
the response rate duration of both induction treatments and both maintenance treatments